- Open Access
Evidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart Study
BMC Genetics volume 4, Article number: S52 (2003)
Epidemiological studies have indicated that obesity and low high-density lipoprotein (HDL) levels are strong cardiovascular risk factors, and that these traits are inversely correlated. Despite the belief that these traits are correlated in part due to pleiotropy, knowledge on specific genes commonly affecting obesity and dyslipidemia is very limited. To address this issue, we first conducted univariate multipoint linkage analysis for body mass index (BMI) and HDL-C to identify loci influencing variation in these phenotypes using Framingham Heart Study data relating to 1702 subjects distributed across 330 pedigrees. Subsequently, we performed bivariate multipoint linkage analysis to detect common loci influencing covariation between these two traits.
We scanned the genome and identified a major locus near marker D6S1009 influencing variation in BMI (LOD = 3.9) using the program SOLAR. We also identified a major locus for HDL-C near marker D2S1334 on chromosome 2 (LOD = 3.5) and another region near marker D6S1009 on chromosome 6 with suggestive evidence for linkage (LOD = 2.7). Since these two phenotypes have been independently mapped to the same region on chromosome 6q, we used the bivariate multipoint linkage approach using SOLAR. The bivariate linkage analysis of BMI and HDL-C implicated the genetic region near marker D6S1009 as harboring a major gene commonly influencing these phenotypes (bivariate LOD = 6.2; LODeq = 5.5) and appears to improve power to map the correlated traits to a region, precisely.
We found substantial evidence for a quantitative trait locus with pleiotropic effects, which appears to influence both BMI and HDL-C phenotypes in the Framingham data.
The incidence rates of complex diseases such as obesity and type 2 diabetes have been increasing worldwide [1, 2]. Obesity is a major risk factor for type 2 diabetes, hypertension, dyslipidemia, and other cardiovascular complications and it has become a global public health problem . Several epidemiological studies have shown that obesity and low levels of high-density lipoprotein cholesterol (HDL-C) are major risk factors for coronary heart disease [4, 5] and there is substantial evidence that obesity and HDL-C are strongly influenced by genetic factors. In fact, a number of studies have identified chromosomal regions harboring quantitative trait loci (QTL) influencing obesity  or dyslipidemia . Surprisingly, little is known about specific loci commonly influencing obesity and HDL-C concentrations, despite the evidence for appreciable correlation between these phenotypes. The present analysis examines whether there exists any chromosomal regions harboring genes that influence the covariation between BMI and HDL-C phenotypes using the Framingham Heart Study data through a bivariate linkage approach.
Subjects and Methods
The Framingham Heart Study
For purposes of the current analysis, Framingham Heart Study participants from the original cohort were combined with participants from the offspring cohort to maximize the number of individuals per pedigree. Information collected as part of the 12th examination (except for height, which was collected at the 14th examination) of the original cohort, which occurred 1970 to 1971, was combined with information collected during the first examination of the offspring cohort, which occurred from 1971 to 1975. Of the more than 10,000 participants enrolled in either the Framingham Heart Study or the Framingham Offspring Study, genotypic information was available on 1702 individuals from 330 extended pedigrees. The pedigrees include from 2 to 29 genotyped individuals and the genotyped sample includes 394 individuals from the original cohort and 1308 individuals from the offspring cohort.
We used BMI and HDL-C data collected as part of the Framingham Heart Study. BMI was calculated as weight (in kilograms)/height squared (in meters). HDL-C (mg/dl) was measured by automated enzymatic methods. BMI and HDL-C values were log transformed to minimize the problem of non-normality.
Variance components linkage analysis
A multipoint variance components linkage analysis was used to test linkage between marker loci and a given phenotype, which was based on specifying the expected genetic covariances between pairs of relatives as a function of their identity by descent (IBD) at a marker linked to a QTL . It allows for locus-specific effects, residual genetic effects, covariate effects, and random environmental effects. Since the trait-specific linkage analysis (i.e., univariate) cannot exploit the additional information embedded in the correlation pattern between two quantitative traits, a bivariate multipoint linkage analysis was used to exploit the additional information contained in the correlation pattern between two quantitative traits [9, 10].
Univariate genetic linkage analysis
In a simple additive model in which n QTLs and an unknown number of residual polygenes influence a given trait, the covariance matrix (Ω) for a pedigree is given by
where Πi is a matrix whose elements (πijl) provide the expected proportion of genes that individuals j and l share IBD at a QTL (qi) that is linked to a genetic marker locus, σ2q is the additive genetic variance due to the major locus, Φ is the kinship matrix, σ2g is the genetic variance due to additive genetic effects, I is an identity matrix, and σ2e is the variance due to random environmental effects.
Bivariate genetic linkage analysis
The extension of the variance components linkage approach to the bivariate situation facilitates the testing of linkage of two correlated phenotypes to a single genetic region simultaneously. In the bivariate analysis, trait-specific means, variance components relating to major gene effects (σ2q), residual additive genetic effects (σ2g), random environmental effects (σ2e), covariate effects (age and sex terms), as well as the three associated correlations ρq (correlation caused by a major gene), ρg (correlation caused by residual additive genetic effects), and ρe (correlation caused by random environmental effects) are estimated simultaneously using maximum-likelihood estimates. Using this bivariate model, we tested the null hypothesis that σ2q = 0 for both traits by comparing the log likelihood of this restricted model to that of a model in which σ2q was estimated for the traits. In addition, tests for the hypotheses of complete pleiotropy (i.e., the same major gene in the chromosomal region of interest affects both traits) and coincident linkage (i.e., no shared major gene effects in the chromosomal region of interest on the two traits) can be performed . To test complete pleiotropy or coincident linkage, likelihood for the linkage model in which ρq was estimated was compared with the model in which ρq was constrained to -1 (complete pleiotropy [a negative value for ρq was chosen since the overall polygenic correlation between the examined traits was found to be negative]) or to 0 (coincident linkage [i.e., ρq = 0]), respectively. These analytical techniques were implemented in the computer program SOLAR .
Descriptive statistics for the examined phenotypes are reported in Table 1. To minimize the problem of non-normality, BMI and HDL-C values were log transformed. Both phenotypes exhibited high heritabilities (h2 ± SE, ln BMI = 0.45 ± 0.05 and ln HDL-C = 0.52 ± 0.06), after adjusting for age and sex influences.
As shown in Figure 1, univariate multipoint linkage analysis yielded significant evidence for linkage with ln BMI (LOD = 3.9) and suggestive evidence with ln HDL-C (LOD = 2.7, 150 cM) on chromosome 6. The chromosomal region at 158 cM near markers D6S1009 and GATA184A08 on chromosome 6 showed evidence for linkage to both BMI and HDL-C, although the trait-specific linkage curves peaked at two adjacent locations covering about an 8cM region (Figure 1). Both genetic (-0.26) and environmental (-0.17) correlations between BMI and HDL-C were low. Subsequently, we extended our analytical approach to the bivariate situation to exploit the additional information underlying the pattern of covariation between ln BMI and ln HDL-C phenotypes.
Table 2 presents the results from multipoint bivariate linkage analyses of ln BMI and ln HDL-C. A bivariate LOD score of 6.24 was obtained for the region involving the ordered markers D6S1009-GATA184A08 for the trait pair of ln BMI-ln HDL-C (Figure 2). The corresponding p-value is 1.8 × 10-7 (λ = 28.75). The bivariate LOD score can be converted to univariate LOD equivalent (LODeq) of 5.46 for this chromosomal region, which adds further significance to our finding. The correlation (ρq ± SE) between trait pair ln BMI-ln HDL-C due to QTL effects is -0.54 ± 0.19, which is statistically significant (p = 0.0072). It should be noted that the test for complete pleiotropy (i.e., locus-specific correlation between ln BMI and ln HDL is not significantly different from -1) was rejected (p = 0.0166). However, coincident linkage (i.e., locus-specific correlation between ln BMI and ln HDL is equal to 0) for ln BMI and ln HDL was strongly rejected (p = 0.0072).
The univariate linkage analyses implicated ~8cM chromosomal region, involving the sequential markers D6S1009-GATA184A08, on chromosome 6q influencing both ln BMI and ln HDL-C. The genetic correlation between ln BMI and ln HDL was higher compared with environmental correlation and showed an inverse relationship as expected. This pattern of correlation is consistent with previous observations in which low overall genetic correlations were observed between obesity and lipid measures in a Mexican-American population . Since both ln BMI and ln HDL-C have exhibited significant linkage to the same region on chromosome 6q, we specifically examined the mapping pattern of the bivariate trait. The bivariate analysis has resulted in co-localization of these correlated traits at a chromosomal region near marker D6S1009. The tests for complete pleiotropy and coincident linkage indicated that the putative major gene influences both BMI and HDL-C, albeit incompletely. As remarked by Almasy et al. , such a situation of incomplete pleiotropy would be expected if either epistatic or gene × environmental interactions influence the putative major gene's effect on one of the two correlated traits, but not both. Also, it is possible that multiple variants in a putative major gene may differentially influence the correlated phenotypes.
It appears that the trait pairs with low to moderate overall genetic correlations (BMI vs. HDL-C) appear to contain much more information to improve power to co-localize precisely the correlated phenotypes to a genetic region. It is important to note that this same region (or genetic locations close to this region) on chromosome 6q has been reported to affect various components of the Insulin Resistance Syndrome including obesity, insulin, lipid, and blood pressure measures [e.g., [12–14]]. Recently, Atwood et al.  reported evidence for linkage of the same region on chromosome 6q23-25 (D6S1009-GATA184A08-D6S2436-D6S305) with six separate measurements of BMI with corresponding maximum LOD scores of 4.64, 2.29, 2.41, 1.40, 0.99, and 3.08, respectively, collected across 28 years of the Framingham Heart Study. This study provides additional evidence in support of the implicated region on chromosome 6 harboring the QTL affecting BMI variation in Framingham data.
Using a bivariate linkage approach, we have found strong evidence for a QTL, which appears to influence both BMI and HDL-C, in Framingham data. Our study suggests that the putative locus lies in the chromosomal region near marker D6S1009 on chromosome 6.
Burke JP, Williams K, Gaskill SP, Hazuda HP, Haffner SM, Stern MP: Rapid rise in the incidence of type 2 diabetes from 1987 to 1996-results from the San Antonio Heart Study. Arch Intern Med. 1999, 159: 1450-1456. 10.1001/archinte.159.13.1450.
Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA. 1999, 282: 1523-1529. 10.1001/jama.282.16.1523.
Sorensen TIA: The changing lifestyle in the world. Diabetes Care. 2000, 23 (suppl 2): B1-B4.
Vogler GP, McClearn GE, Snieder H, Boomsma DI, Palmer R, de Knijff P, Slagboom PE: Genetics and behavioral medicine: risk factors for cardiovascular disease. Behav Med. 1997, 22: 141-149.
Genest J, Marcil M, Denis M, Yu L: High density lipoproteins in health and disease. J Clin Invest. 1999, 47: 31-42.
Comuzzie AG, Williams JT, Martin LJ, Blangero J: Searching for genes underlying normal variation in human adiposity. J Mol Med. 2001, 79: 57-70. 10.1007/s001090100202.
Hegele RA: Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism. Am J Hum Genet. 2001, 69: 1161-1177. 10.1086/324647.
Almasy L, Blangero J: Multipoint quantitative trait linkage analysis in general pedigrees. Am J Hum Genet. 1998, 62: 1198-1211. 10.1086/301844.
Almasy L, Dyer TD, Blangero J: Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol. 1997, 14: 953-958. 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K.
Williams JT, Begleiter H, Porjesz B, Edenberg HJ, Foroud T, Reich T, Goate A, Van Eerdewegh PV, Almasy L, Blangero J: Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. II. Alcoholism and event-related potentials. Am J Hum Genet. 1999, 65: 1148-1160. 10.1086/302571.
Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, O'Connell P, Stern MP: Bivariate quantitative trait linkage of phenotypes related to the insulin resistance syndrome to a genetic region on chromosome 7 in Mexican Americans. Paper presented at the 2nd Research Symposium on the Genetics of Diabetes. San Jose, October 17-19. 1999
Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnuson VL, Mohlke KL, Silander K, Ally DS, Chines P, Blaschak-Harvan J, Douglas JA, Duren WL, Epstein MP, Fingerlin TE, Kaleta HS, Lange EM, Li C, McEachin RC, Stringham HM, Trager E, White PP, Balow J, Birznieks G, Chang J, Eldridge W: The Finland-United States Investigation of Non-insulin-dependent Diabetes Mellitus Genetics (FUSION) Study: II. An autosomal genome scan for diabetes-related quantitative trait loci. Am J Hum Genet. 2000, 67: 1186-1200.
Duggirala R, Blangero J, Almasy L, Arya R, Dyer TD, Williams K, Leach RJ, O'Connell P, Stern MP: A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity related phenotypes in non-diabetic Mexican Americans. Am J Hum Genet. 2001, 68: 1149-1164. 10.1086/320100.
Arya R, Blangero J, Williams K, Almasy L, Dyer TD, O'Connell P, Leach RJ, Stern MP, Duggirala R: Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican Americans. Diabetes. 2002, 51: 841-847. 10.2337/diabetes.51.3.841.
Atwood LD, Heard-Costa NL, Cupples LD, Jaquish JE, Wilson PWF, D'Agostino RB: Genome wide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet. 2002, 71: 1044-1050. 10.1086/343822.
The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. This research was supported by grants from the National Institutes of Health (R01 DK42273, R01 DK47482, R01 DK53889, and MH59490).
About this article
Cite this article
Arya, R., Lehman, D., Hunt, K.J. et al. Evidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart Study. BMC Genet 4, S52 (2003). https://doi.org/10.1186/1471-2156-4-S1-S52
- Quantitative Trait Locus
- Framingham Heart Study
- Marker D6S1009
- Offspring Cohort
- Major Gene Effect